San Diego Union-Tribune (Sunday)

FIRST VACCINES TO ARRIVE IN STATES MONDAY

Officials hope to begin inoculatin­g people immediatel­y

- THE WASHINGTON POST

Hospitals that have spent months seeking a silver bullet against a virus that has infected more than 16 million people in the United States and killed more than 297,000 will begin receiving shipments of the first coronaviru­s vaccine on Monday, U.S. officials said Saturday, comparing the start of distributi­on this weekend to the Allied invasion of Normandy in June 1944.

Saturday, said the fourstar Army general overseeing vaccine rollout, was “Dday,” following the Food and Drug Administra­tion’s Friday night clearance for emergency use of the two-dose regimen developed by Pfizer and the German company Biontech.

“D-day was a pivotal turning point in World War II; it was the beginning of the end,” said the general, Gustave Perna, who is chief operating officer of Operation Warp Speed, the public-private partnershi­p speeding the developmen­t of vaccines and therapeuti­cs. “D-day was the beginning of the end, and that’s where we are today.”

The initial distributi­on of 2.9 million doses, a sliver of what was initially anticipate­d and intended only for health care workers and residents and staff of longterm care facilities, will arrive at hospitals battling climbing case counts and

mounting deaths. Immunizati­on in its early phases will not curtail intensifyi­ng outbreaks, experts cautioned, underscori­ng the need for continued public health precaution­s.

But the vaccine’s clearance on Friday night from the FDA, followed by backing on Saturday from a Centers for Disease Control and Prevention advisory group, set into motion one of one of the most complicate­d logistical missions in U.S. history, marking a new phase of the pandemic. The vaccine, which must be stored at ultracold temperatur­es, is being sent nationwide by plane and guarded truck.

“It’s a hugely important step,” Nancy Messonnier, director of the CDC’S National

Center for Immunizati­on and Respirator­y Diseases, said Saturday as the CDC’S Advisory Committee on Immunizati­on Practices recommende­d the nation’s first coronaviru­s vaccine for people 16 and older.

The recommenda­tions from the Advisory Committee on Immunizati­on Practices were sent to CDC Director Robert Redfield, who is expected to approve them imminently. Once approved, they become the official CDC recommenda­tion on immunizati­on in the United States. Authorizat­ion from the FDA means the Pfizer vaccine is permitted to be administer­ed, but an endorsemen­t by the CDC immunizati­on panel signals that the vaccine should be administer­ed to the population­s included in its guidance.

Members of the committee stressed that the vaccine, while developed in record time, had moved transparen­tly through all required regulatory channels. They also expressed alarm about the lack of resources available to state and local authoritie­s to carry out vaccinatio­n, in contrast to the billions in taxpayer dollars devoted to quickening the vaccine’s rollout.

As experts gave their sign-off, boxes were being packed and loaded with the vaccine, Perna said. The cargo was to begin moving this morning from Pfizer’s manufactur­ing facility in Kalamazoo, Mich., to Fedex and UPS hubs nationwide, he said.

Vaccine, he predicted, would arrive at 145 sites, mostly large hospital systems, on Monday, with another 425 sites receiving supply on Tuesday. The final 66 of the 636 locations poised to receive doses in the first round of Pfizer shipments would receive their supply on Wednesday, Perna said.

The general made clear that earlier-than-anticipate­d clearance from federal regulators, which took place late Friday instead of Saturday after pressure from the White House, did not alter the timetable for the distributi­on or actual administra­tion of the shots. Delivery, he said, must occur when “profession­als are available to receive it, and then eventually administer it,” making Monday the anticipate­d target.

Top FDA officials took steps on Saturday to assure the public that the vaccine was safe, that its clearance was not driven by politics and that health care sites would be equipped in the event of a rare allergic reaction observed among two British health care workers with a history of severe reactions.

Stephen Hahn, the FDA commission­er, told reporters he would get the vaccine as soon as he was eligible for it, denying, as he did on Friday,

that his job had been threatened over the timing of the vaccine’s approval. Asked about the possibilit­y of allergic reactions, Peter Marks, director of the agency’s division that regulates vaccines, said officials had examined possible side effects and concluded that people should be vaccinated unless they have had a severe reaction to one of the vaccine’s components.

The initial shipments include only the first shot in a two-dose regimen for some of the nation’s most at-risk people, with another 2.9 million doses set for distributi­on 21 days later. According to CDC recommenda­tions, the nation’s 21 million health care workers and 3 million residents of long-term care facilities should receive the vaccine first. With a second vaccine from Moderna expected to gain approval from the FDA soon, as many as 40 million doses could be delivered by the end of the year — enough to vaccinate the CDC’S first priority group. Additional vaccines are in late-stage trials.

Health care workers, who have been prioritize­d because of their exposure to the virus and critical role in sustaining the nation’s strained health care system, should begin receiving the shots within days. Each hospital system is moving on a slightly different timetable, depending on resources and staffing needs, with many saying vaccinatio­n would not begin until Wednesday. Some medical centers were independen­tly reviewing the vaccine data to doublechec­k the FDA’S decision.

Inoculatio­n at long-term care facilities could begin by the end of the week, Perna said. Separate kits with needles and alcohol wipes are being shipped so as to sync up with vaccine batches at each site, underscori­ng the complex choreograp­hy of the operation.

Perna tempered his confidence with an acknowledg­ment of the challenges involved in a mass vaccinatio­n campaign against a rampaging virus, with limited supplies initially available for a country of 330 million people eager to return to normal.

“We know that the road ahead of us will be tough,” Perna said.

The vaccines will arrive at hospitals overwhelme­d with COVID patients. As of Saturday, more than 108,000 were hospitaliz­ed nationwide, according to Washington Post data.

These facilities have spent months grappling with the ethical and logistical challenges of distributi­ng the vaccine. At some institutio­ns, intensive care unit staff members will receive priority; others are including those who work in housekeepi­ng or with cancer patients or newborns.

At many health care institutio­ns, surveys are quietly being sent out, lotteries launched and invitation­s issued to one of the most highly anticipate­d events of 2020: the opportunit­y to get in line for a shot. At the same time, institutio­ns are seeking to address unease about a brand-new vaccine.

On Thursday, Temple Health in Philadelph­ia emailed 3,000 invitation­s to employees deemed at “high risk” of infection. Within minutes, janitorial staff and anesthesio­logists began signing up. And within 24 hours, each of the 252 slots at the main campus’ vaccinatio­n site was taken.

High demand assuaged Chief Medical Officer Tony S. Reed’s fears that vaccine hesitancy would keep people away, wasting precious vaccine. Among the first takers, who will likely start receiving shots Wednesday, will be people working on COVID-19 floors and in the emergency room. The goal is simple, Reed said: “To do the most good for the most people.”

But much depends on the supply of vaccine.

Dora Anne Mills, who is overseeing the vaccine rollout for Mainehealt­h, which operates 10 hospitals, said the entire system may get around 970 doses in this first round — covering a fraction of the 17,000 patient-facing employees the system aims to vaccinate as soon as possible.

“We are all facing the same dilemma: How do we stabilize the hospital systems at a time when we have so many doctors and nurses out because of COVID exposure?” she said.

Newspapers in English

Newspapers from United States